The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.
Cancer and the chemokine network
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CXCL1 and 2 are 90% identical by amino-acid sequence and signal through the same receptor CXCR2 (Balkwill, 2004).”
From A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis (2012) · cites this paper as Balkwill, 2004
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Self-citationInternational Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,414
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,605
Research works printed but not linked: 1
- Darash-Yahana, M. et al. Human prostate cancer growth, vascularisation and metastasis is stimulated via high expression levels of the chemokine receptor CXCR4. Proc. Am. Assoc. Cancer Res. 44, 789 (2003).
Cited by
Sorted by citations
Items 601–700 of 1,000
Gavard, J., Hou, X., Qu, Y., Masedunskas, A., Martı́n, D., Weigert, R., Li, X., & Gutkind, J. S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01304-08 · Cited by 80
Inflammation-Induced Hepatocellular Carcinoma Is Dependent on Ccr5 in Mice
Barashi, N., Weiss, I. D., Wald, O., Wald, H., Beider, K., Abraham, M., Klein, S., Goldenberg, D., Axelrod, J. H., Pikarsky, E., et al. (2013) · Hepatology · doi:10.1002/hep.26403 · Cited by 79
Physiology and Pharmacology of Plerixafor
Fricker, S. P. (2013) · Transfusion Medicine and Hemotherapy · doi:10.1159/000354132 · Cited by 77
Li, L., Yan, J., Xu, J., Liu, C.-Q., Zhen, Z. J., Chen, H., Ji, Y., Wu, Z.-P., Hu, J. Y., Zheng, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110064 · Cited by 76
Książkiewicz, M., Gottfried, E., Kreutz, M. P., Mack, M., Hofstaedter, F., & Kunz‐Schughart, L. A. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.019 · Cited by 76
Insights into the Role of Follicular Helper T Cells in Autoimmunity
Park, H.-J., Kim, D.-H., Lim, S., Kim, W., Youn, J., Choi, Y.-S., & Choi, J. (2014) · Immune Network · doi:10.4110/in.2014.14.1.21 · Cited by 77
Macrophage migration inhibitory factor: A key cytokine and therapeutic target in colon cancer
Gordon-Weeks, A. N., Lim, S. Y., Yuzhalin, A. E., Jones, K. I., & Muschel, R. J. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.03.002 · Cited by 75
Tumor Cells Induce LAMP2a Expression in Tumor-Associated Macrophage for Cancer Progression
Wang, R., Liu, Y., Liu, L., Chen, M., Wang, X., Yang, H. J., Gong, Y., Ding, B., Wei, Y., & Wei, X. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.045 · Cited by 76
The Role of tumor-associated macrophage in tumor progression
Watabe, K. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s299 · Cited by 75
Derdák, Z., Fülöp, P., Sabo, E., Tavares, R., Berthiaume, E. P., Resnick, M. B., Paragh, G., Wands, J. R., & Baffy, G. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi335 · Cited by 77
Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer
Liu, B., Jia, Y., Ma, J., Wu, S., Jiang, H., Cao, Y., Sun, X., Yin, X. L., Yan, S., Shang, M., et al. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw101 · Cited by 75
Pathomechanisms: homeostatic chemokines in health, tissue regeneration, and progressive diseases
Anders, H., Romagnani, P., & Mantovani, A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.12.002 · Cited by 77
Sadlonova, A., Bowe, D. B., Novák, Z., Mukherjee, S., Duncan, V. E., Page, G. P., & Frost, A. R. (2009) · Cancer Microenvironment · doi:10.1007/s12307-008-0017-0 · Cited by 74
One microenvironment does not fit all: heterogeneity beyond cancer cells
Kim, I. S., & Zhang, X. H.-F. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9643-z · Cited by 75
Targeting key steps in metastatic tumour progression
Eccles, S. A. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.001 · Cited by 73
Brennecke, P., Arlt, M., Campanile, C., Husmann, K., Gvozdenovic, A., Apuzzo, T., Thelen, M., Born, W., & Fuchs, B. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9632-3 · Cited by 73
Huang, B., Han, W., Sheng, Z.-F., & Shen, G. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01271-2 · Cited by 74
Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment
Pagano, E., Elias, J. E., Schneditz, G., Saveljeva, S., Holland, L. M., Borrelli, F., Karlsen, T. H., Kaser, A., & Kaneider, N. C. (2021) · Gut · doi:10.1136/gutjnl-2020-323363 · Cited by 76
Minina, S., Reichman‐Fried, M., & Raz, E. (2007) · Current Biology · doi:10.1016/j.cub.2007.05.073 · Cited by 74
Wendel, C., Hemping-Bovenkerk, A., Krasnyanska, J., Mees, S. T., Kochetkova, M., Stöppeler, S., & Haier, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030046 · Cited by 73
Shibata, W., Ariyama, H., Westphalen, C. B., Worthley, D. L., Muthupalani, S., Asfaha, S., Dubeykovskaya, Z. A., Quante, M., Fox, J. G., & Wang, T. C. (2013) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · doi:10.1136/gutjnl-2011-301824 · Cited by 73
Jensen, K. K., Manfra, D. J., Grisotto, M. A. G., Martin, A. P., Vassileva, G., Kelley, K. A., Schwartz, T. W., & Lira, S. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3686 · Cited by 73
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
Wong, D., Kandagatla, P., Korz, W., & Chinni, S. R. (2014) · BMC Urology · doi:10.1186/1471-2490-14-12 · Cited by 72
Staphylococcal Superantigen-like 10 Inhibits CXCL12-Induced Human Tumor Cell Migration
Walenkamp, A., Boer, I. G. J., Bestebroer, J., Rozeveld, D., Timmer‐Bosscha, H., Hemrika, W., van Strijp, J. A. G., & de Haas, C. J. C. (2009) · Neoplasia · doi:10.1593/neo.81508 · Cited by 72
Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma
Wente, M. N. (1992) · International Journal of Oncology · doi:10.3892/ijo_00000009 · Cited by 72
Oliveira-Neto, H. H., Leite, A. F., Costa, N. L., Alencar, R. C. G., Lara, V. S., Silva, T. A., Leles, C. R., Mendonça, E. F., & Batista, A. C. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.05.004 · Cited by 72
An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells
Kwong, J., Kulbe, H., Wong, D., Chakravarty, P., & Balkwill, F. R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0966 · Cited by 75
Self-citationHuman antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis
Lee, S., Park, K.-K., Kim, H., Park, J., Son, S. H., Kim, K., & Chung, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-09040-4 · Cited by 72
Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pylori
Suganuma, M., Watanabe, T., Yamaguchi, K., Takahashi, A., & Fujiki, H. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.027 · Cited by 71
Role of CXC group chemokines in lung cancer development and progression
Špaks, A. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.03.61 · Cited by 71
Revisiting the impact of lifestyle on colorectal cancer risk in a gender perspective
Conti, L., Cornò, M. D., & Gessani, S. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102834 · Cited by 75
Macrophages and the hypoxic tumour microenvironment
Knowles, H. J. (2007) · Frontiers in bioscience · doi:10.2741/2389 · Cited by 71
Haberstock, S., Roos, C., Hoevels, Y., Dötsch, V., Schnapp, G., Pautsch, A., & Bernhard, F. (2012) · Protein Expression and Purification · doi:10.1016/j.pep.2012.01.018 · Cited by 71
Iida, N., Nakamoto, Y., Baba, T., Nakagawa, H., Mizukoshi, E., Naito, M., Mukaida, N., & Kaneko, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0096 · Cited by 74
Erreni, M., Solinas, G., Brescia, P., Osti, D., Zunino, F., Colombo, P., Destro, A., Roncalli, M. G., Mantovani, A., Draghi, R., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.022 · Cited by 70
Marttila‐Ichihara, F., Auvinen, K., Elima, K., Jalkanen, S., & Salmi, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1205 · Cited by 71
Malvi, P., Chaube, B., Pandey, V., Vijayakumar, M. V., Boreddy, P. R., Mohammad, N., Singh, S. V., & Bhat, M. K. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.006 · Cited by 70
Yang, C., Yu, H., Chen, R., Tao, K. X., Lei, J., Peng, M., Li, X., Liu, M., & Liu, S. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4840 · Cited by 70
CCR7 Mediates Inflammation-Associated Tumor Progression
Mburu, Y. K., Wang, J., Wood, M. A., Walker, W. H., & Ferris, R. L. (2006) · Immunologic Research · doi:10.1385/ir:36:1:61 · Cited by 70
Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions
Rüegg, C. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606394 · Cited by 70
Zeng, Y., Huebener, N., Fest, S., Weixler, S., Schroeder, U., Gaedicke, G., Xiang, R., Schramm, A. R., Eggert, A., Reisfeld, R. A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3041 · Cited by 70
Yeh, C., Slavin, S. A., Da, J., Hsu, I., Luo, J., Xiao, G., Ding, J., Chou, F.-J., & Yeh, S. (2016) · Molecular Cancer · doi:10.1186/s12943-015-0488-9 · Cited by 70
GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells
Katsumura, K. R., Ong, I. M., DeVilbiss, A., Sanalkumar, R., & Bresnick, E. H. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.058 · Cited by 70
Lv, B., Yang, X., Lv, S., Wang, L., Fan, K., Shi, R., Wang, F., Song, H., Ma, X., Tan, X., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8935-y · Cited by 68
RetractedLee, C.-C., Liu, K.-J., Wu, Y.-C., Lin, S.-J., Chang, C.-C., & Huang, T. (2010) · Inflammation · doi:10.1007/s10753-010-9226-z · Cited by 69
Yagi, H., Seo, N., Ohshima, A., Itoh, T., Itoh, N., Horibe, T., Yoshinari, Y., Takigawa, M., & Hashizume, H. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213267.92349.59 · Cited by 69
Hu, W., Zhen, X., Xiong, B., Wang, B., Zhang, W., & Zhou, W. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00833.x · Cited by 69
The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review)
Liao, Y., Zhou, C., Zeng, H. M., Zuo, D., Wang, Z., YIN, F., HUA, Y.-Q., & CAI, Z.-D. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1521 · Cited by 70
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations
Mateo, F., Meca‐Cortés, Ó., Celià-Terrassa, T., Fernández, Y., Abasolo, I., Sánchez‐Cid, L., Bermudo, R., Sagasta, A., Rodríguez‐Carunchio, L., Pons, M., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-237 · Cited by 69
Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Sun, F., Chan, E., Wu, Z., Yang, X., Márquez, V. E., & Yu, Q. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0479 · Cited by 69
CCL5-deficiency enhances intratumoral infiltration of CD8+ T cells in colorectal cancer
Zhang, S., Zhong, M., Wang, C., Xu, Y., Gao, W., & Zhang, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0796-2 · Cited by 70
Blanc, R. S., Kallenbach, J. G., Bachman, J. F., Mitchell, A., Paris, N. D., & Chakkalakal, J. V. (2020) · Nature Communications · doi:10.1038/s41467-020-17620-8 · Cited by 71
CXCL5 as Regulator of Neutrophil Function in Cutaneous Melanoma
Forsthuber, A., Lipp, K., Andersen, L., Ebersberger, S., Graña‐Castro, O., Ellmeier, W., Petzelbauer, P., Lichtenberger, B. M., & Loewe, R. P. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.07.006 · Cited by 68
Martı́n, D., Galisteo, R., Ji, Y., Montaner, S., & Gutkind, J. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210817 · Cited by 68
Clinical opportunities and challenges in targeting tumour dormancy
Hensel, J. A., Flaig, T. W., & Theodorescu, D. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.207 · Cited by 68
CC Chemokine Receptor 5: The Interface of Host Immunity and Cancer
de Oliveira, C. E. C., Oda, J. M. M., Guembarovski, R. L., de Oliveira, K. B., Ariza, C. B., Neto, J. S., Hirata, B. K. B., & Watanabe, M. A. E. (2014) · Disease Markers · doi:10.1155/2014/126954 · Cited by 68
Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game
Través, P. G., Luque, A., & Hortelano, S. (2012) · Mediators of Inflammation · doi:10.1155/2012/568783 · Cited by 71
New insights into perineural invasion of pancreatic cancer: More than pain
Liang, D., Shi, S., Xu, J., Zhang, B., Qin, Y., Ji, S., Xu, W., Liu, J., Liu, L., Liu, C., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.002 · Cited by 66
Qian, D., Lu, Z., Xu, Q., Wu, P., Tian, L., Zhao, L., Cai, B., Yin, J., Wu, Y. F., Staveley-O’Carroll, K. F., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.024 · Cited by 68
Role of G12 proteins in oncogenesis and metastasis
Juneja, J., & Casey, P. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00180.x · Cited by 68
Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients
Mosadegh, B., Saadi, W. M., Wang, S., & Jeon, N. L. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21851 · Cited by 68
Cell invasion through basement membranes: an anchor of understanding
Sherwood, D. R. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.03.004 · Cited by 67
Molina‐Ortiz, I., Bartolomé, R. A., Hernández-Varas, P., Coló, G. P., & Teixidó, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807834200 · Cited by 68
Ramos, E. A., Camargo, A. A., Braun-Prado, K., Slowik, R., Cavalli, I. J., Ribeiro, E. M. S. F., Pedrosa, F. D. O., de Souza, E. M., Costa, F. F., & Klassen, G. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-23 · Cited by 67
Szpakowska, M., Nevins, A. M., Meyrath, M., Rhainds, D., D’huys, T., Guité‐Vinet, F., Dupuis, N., Gauthier, P., Counson, M., Kleist, A. B., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14132 · Cited by 66
Robert, J. (2013) · Bulletin du Cancer · doi:10.1684/bdc.2013.1724 · Cited by 67
Th17 cells regulate the production of CXCL1 in breast cancer
Ma, K., Yang, L., Shen, R., Kong, B., Chen, W., Liang, J., Tang, G., & Zhang, B. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.01.026 · Cited by 65
CXCL8 Signaling in the Tumor Microenvironment
Asokan, S., & Bandapalli, O. R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-62658-7_3 · Cited by 66
Cytokeratin and Vimentin Expression in Breast Cancer
Vora, H. H., Patel, N., Rajvik, K. N., Mehta, S. V., Brahmbhatt, B. V., Shah, M., Shukla, S. N., & Shah, P. M. (2009) · The International Journal of Biological Markers · doi:10.1177/172460080902400106 · Cited by 66
Gaudin, F., Nasreddine, S., Donnadieu, A.-C., Émilie, D., Combadière, C., Prevot, S., Machelon, V., & Balabanian, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021546 · Cited by 69
Wound Healing after Trauma May Predispose to Lung Cancer Metastasis
Walter, N. D., Rice, P. L., Redente, E. F., Kauvar, E. F., Lemond, L. M., Aly, T. A., Wanebo, K., & Chan, E. D. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0187rt · Cited by 66
Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists
Truax, V. M., Zhao, H., Katzman, B. M., Prosser, A. R., Alcaraz, A. A., Saindane, M., Howard, R. B., Culver, D. G., Arrendale, R. F., Gruddanti, P. R., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400183q · Cited by 66
The structural network of inflammation and cancer: Merits and challenges
Guven‐Maiorov, E., Keskin, Ö., Gürsoy, A., & Nussinov, R. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.05.003 · Cited by 66
Lymphoma microenvironment: culprit or innocent?
Herreros, B., Sánchez‐Aguilera, A., & Piris, M. A. (2007) · Leukemia · doi:10.1038/sj.leu.2404970 · Cited by 66
Igreja, C., Courinha, M., Cachaço, A. S., Pereira, T., Cabeçadas, J., da Silva, M. G., & Dias, S. (2007) · Haematologica · doi:10.3324/haematol.10723 · Cited by 66
FDG-PET imaging in hematological malignancies
Valls, L., Badve, C. A., Avril, S., Herrmann, K., Faulhaber, P., O’Donnell, J. K., & Avril, N. E. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.02.003 · Cited by 66
Knockdown of long non-coding RNA H19 inhibits multiple myeloma cell growth via NF-κB pathway
Sun, Y., Pan, J., Zhang, N., Wei, W., Yu, S., & Ai, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-18056-9 · Cited by 66
Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia
Hattermann, K., Sebens, S., Helm, O., Schmitt, A. D., Mentlein, R., Mehdorn, H. M., & Held‐Feindt, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3214 · Cited by 65
Influence of Magnetic Fields on Magneto-Aerotaxis
Bennet, M. A., McCarthy, A., Fix, D., Edwards, M. R., Repp, F., Vach, P. J., Dunlop, J., Sitti, M., Buller, G. S., Klumpp, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101150 · Cited by 65
Eiró, N., Pidal, I., Fernández‐García, B., Junquera, S., Lamelas, M. L., del Casar, J. M., González, L. O., Lopez-Muniz, A., & Vizoso, F. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052796 · Cited by 65
Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune Therapy
Cheadle, E. J., Riyad, K., Subar, D. A., Rothwell, D. G., Ashton, G., Batha, H., Sherlock, D., Hawkins, R. E., & Gilham, D. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1145 · Cited by 65
Effect of low frequency magnetic fields on melanoma: tumor inhibition and immune modulation
Nie, Y., Du, L., Mou, Y., Xu, Z., Weng, L., You-Wei, D., Zhu, Y., Hou, Y., & Wang, T. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-582 · Cited by 65
AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells
Zhang, W., Wu, Q., Wang, C., Yang, L., Liu, P., & Ma, C. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3335-7 · Cited by 65
Yu, D. N., Li, Y., Ming, Z., Wang, H., Dong, Z., Qiu, L., & Wang, T. (2018) · PeerJ · doi:10.7717/peerj.5011 · Cited by 64
CCR5 is a potential therapeutic target for cancer
Hemmatazad, H., & Berger, M. D. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1902505 · Cited by 64
Nie, F., Zhang, J., Tian, H., Zhao, J., Gong, P., Wang, H., Wang, S., Yang, P., & Yang, C. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06640-7 · Cited by 68
Kubisch, R., Fröhlich, T., Arnold, G. J., Schreiner, L., von Schwarzenberg, K., Roidl, A., Vollmar, A. M., & Wagner, E. (2013) · International Journal of Cancer · doi:10.1002/ijc.28562 · Cited by 67
Chemokines: key players in cancer progression and metastasis
Singh, R. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/246 · Cited by 66
CCL20/CCR6 expression profile in pancreatic cancer
Rubie, C., Frick, V. O., Ghadjar, P., Wagner, M., Grimm, H., Vicinus, B., Justinger, C., Graeber, S. M., & Schilling, M. K. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-45 · Cited by 64
Kim, M., Rooper, L. M., Xie, J., Kajdacsy‐Balla, A., & Barbolina, M. V. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0256 · Cited by 64
Fugetaxis: active movement of leukocytes away from a chemokinetic agent
Vianello, F., Olszak, I. T., & Poznansky, M. C. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0675-z · Cited by 65
Macrophages and pancreatic ductal adenocarcinoma
Habtezion, A., Edderkaoui, M., & Pandol, S. J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.049 · Cited by 66
Dong, L., You, S., Zhang, Q., Osuka, S., Devi, N. S., Kaluz, Š., Ferguson, J. H., Yang, H., Chen, G., Wang, B., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1368 · Cited by 64
Tang, J., Chen, Z., Sun, B., Dong, J., Liu, J., Zhou, H., Wang, L., Bai, R., Miao, Q., Zhao, Y., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.11.021 · Cited by 63
Malvi, P., Chaube, B., Singh, S. V., Mohammad, N., Vijayakumar, M. V., Singh, S., Chouhan, S., & Bhat, M. K. (2018) · Cancer & Metabolism · doi:10.1186/s40170-018-0176-5 · Cited by 63
CCR5-Mediated Signaling is Involved in Invasion of Glioblastoma Cells in Its Microenvironment
Novak, M., Krajnc, M. K., Hrastar, B., Breznik, B., Majc, B., Mlinar, M., Rotter, A., Porčnik, A., Mlakar, J., Stare, K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124199 · Cited by 63
An, H., Hou, D., Yang, J., Wang, Z., Wang, M., Zheng, R., Zhang, N.-Y., Hu, X., Wang, Z., Wang, L., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq8225 · Cited by 63
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
Lasorsa, F. M., Rutigliano, M., Milella, M., Ferro, M., Pandolfo, S. D., Crocetto, F., Riccardo Autorino, B., Battaglia, M., Ditonno, P., & Lucarelli, G. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713179 · Cited by 63
Mimeault, M., & Batra, S. K. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.08.001 · Cited by 65
Current status of chemokine receptor inhibitors in development
Allegretti, M., Cesta, M. C., Garin, A., & Proudfoot, A. E. I. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.04.003 · Cited by 62
Metadata
- Authors
- Balkwill, F.
- Venue
- Nature Reviews Cancer
- Published
- 2004-07
- Volume
- 4
- Issue
- 7
- Pages
- 540-550
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1986986419
- Cited by
- 2,343
- References
- 102
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 57 · 2023: 82 · 2022: 112 · 2021: 132 · 2020: 122 · 2019: 84 · 2018: 131 · 2017: 127 · 2016: 134 · 2015: 133 · 2014: 152 · 2013: 119 · 2012: 135
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- chemokines, chemokine receptors, carcinogenesis, metastasis, tumor-host interaction, metastatic potential, site-specific metastasis, chemokine receptor antagonists, inflammation, autoimmune disease, cancer therapy
- MeSH terms
- Animals, Antineoplastic Agents, Autoimmune Diseases, Chemotaxis, Leukocyte, Humans, Inflammation, Macrophage Activation, Mice, Nude, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Proteins, Neoplasms, Lymphocytes, Tumor-Infiltrating, Chemokines, Receptors, Chemokine, Xenograft Model Antitumor Assays, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review